The relationship between platelet and leukocyte activation, coagulation, and neointima development was investigated in noninjured murine blood vessels subjected to blood stasis. The left common carotid artery of C57BL/6J mice was ligated proximal to the bifurcation. Tissue-factor expression in luminal leukocytes progressively increased over 2 weeks. On day 3 after ligation, in addition to infiltrated granulocytes, platelet microthrombi and platelet-covered leukocytes as well as tissue-factor-positive fibrin deposits lined the endothelium. Maximal neointima formation in carotid artery cross sections of control mice equaled 28Ϯ3.7% (nϭ11) and 42Ϯ5.1% (nϭ8) of the internal elastic lamina cross-sectional area 1 and 2 weeks after ligation. In FVIII Ϫ/Ϫ mice, stenosis was significantly lower 1 (11Ϯ3.6%, nϭ8) and 2 (21Ϯ4.7%, nϭ7) weeks after ligation (both PϽ0.01 versus background-matched controls). In u-PA Ϫ/Ϫ mice, luminal stenosis was significantly higher 1 (38Ϯ7.0%, nϭ7) and 2 (77Ϯ5.6%, nϭ6) weeks after ligation (PϽ0.05 and PϽ0.01, respectively, versus matched controls). In ␣ 2 -AP Ϫ/Ϫ mice, stenosis was lower at 1 week (14Ϯ2.6%, nϭ7, PϽ0.01) but not at 2 weeks. Responses in tissue-type plasminogen activator or plasminogen activator inhibitor-1 gene-deficient mice equaled that in controls. Reducing plasma fibrinogen levels in controls with ancrod or inducing partial thrombocytopenia with busulfan resulted in significantly less neointima, but inflammation was inhibited only in busulfan-treated mice. We conclude that stasis induces platelet activation, leading to microthrombosis and plateletleukocyte conjugate formation, triggering inflammation and tissue-factor accumulation on the carotid artery endothelium. Delayed coagulation then results in formation of a fibrin matrix, which is used by smooth muscle cells to migrate into the lumen. (Circ Res. 2001;88:159-166.) 
A s early as the 18th century, Hewson demonstrated that blood within an isolated segment of a vein remains fluid for several hours, provided that the vessel is not injured. 1 Blood containing veins, ligated for 30 to 60 minutes, attract leukocytes on the endothelium, but although stasis induces leukocyte migration through the endothelial layer, no platelet adherence, aggregation, or thrombus formation can be detected at this stage. 2 Only when veins are ligated and left in situ for as long as 24 to 72 hours can fibrin and deposition of leukocytes, platelets, and erythrocytes be detected. 3 The existence of hypoxemia in those sites where venous thrombosis commonly originates in humans 4 has suggested that hypoxic endothelial damage is involved in the ultimate development of venous thrombosis.
In addition to causing delayed thrombosis, blood flow reduction also enhances intimal lesion formation in vascular grafts and balloon-injured vessels, [5] [6] [7] implying that alterations in blood flow affect the proliferative response of smooth muscle cells. Kumar and Lindner 8 have developed a model in which blood flow in the common carotid artery of the mouse is arrested by carefully ligating the vessel near the bifurcation. In this model, a neointima develops proximal to the ligation site as a consequence of partial blood stasis, reduced shear stress, enhanced arterial-wall tension proximal to the suture, and leukocyte activation in the absence of additional mechanical vessel injury. P-selectin gene deficiency in this model leads to dramatic reduction in lesion thickness and complete absence of inflammatory cells in carotid artery cross sections 3 and 7 days after ligation. 9 This study concluded that P-selectin is involved in smooth muscle cell migration and proliferation, presumably by mediating leukocyte recruitment and platelet-leukocyte interactions.
Using this carotid artery ligation model, the present study investigates to what extent local coagulation is involved in neointima formation and how coagulation comes about. Using various gene-deficient mice and mice experimentally depleted in plasma fibrinogen or blood platelets, our findings reveal a central role for platelets in mediating tissue factor-dependent coagulation and show luminal fibrin formation to be essential for the development of a neointima.
Materials and Methods

Wild-Type and Gene-Deficient Mice
All animal experiments were reviewed and approved by the Institutional Review Board of the University of Leuven and were performed in accordance with protocols approved by the Institutional Animal Care and Research Advisory Committee. FVIII genedeficient mice were kindly provided by Dr Antonarakis (Division of Medical Genetics, University of Geneva, Switzerland). 10 The urokinase-type plasminogen activator (u-PA), tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor-1 (PAI-1) and ␣ 2 -antiplasmin (␣ 2 -AP) gene-deficient mice were generated via homologous recombination in embryonic stem cells in our department. [11] [12] [13] [14] Genotyping of mice was performed by polymerase chain reaction analysis of tail-tip DNA. 12 Experiments on gene-competent mice were all done in C57BL/6J mice. All mice used in this study were between 8 and 12 weeks old, were of both sexes, and weighed between 20 and 31 g.
Carotid Artery Ligation
The carotid artery ligation model used was described elsewhere. 8 Dissected arteries were embedded in OCT compound (Tissue-Tek, Miles Inc), snap-frozen in precooled 2-methyl butane, and stored at Ϫ70°C until additional use. Seven-micron-thick cross sections were made through the whole frozen artery and stained with H&E. Approximately 100 sections, 28 m apart, were analyzed per artery segment.
Induction of Thrombocytopenia in C57BL/6J Mice
Before a 1-week study, thrombocytopenia was induced in C57BL/6J mice via double-intraperitoneal injection of busulfan at 20 mg/kg, dissolved in polyethylene glycol 400 diluted with saline to 25% just before the injection on days 0 and 3. 15 Surgery and ligation were performed on day 14. On days 14 and 21, circulating platelets, leukocytes, and red blood cells were counted via tail bleeding on a Cell Dyn 1300 (Abbott). Circulating platelet numbers in normal C57BL/6J mice were 8.7Ϯ0.57ϫ10 5 /L (nϭ8). At day 14 after thrombocytopenia induction, platelet numbers were 2.1Ϯ0.18ϫ10 5 /L (nϭ6), and at day 21, platelet numbers were 3.7Ϯ0.41ϫ10 5 /L (nϭ6). Before a 2-week study, thrombocytopenia was induced in C57BL/6J mice via double-intraperitoneal injection of busulfan at 20 mg/kg on days 0 and 3 followed by intravenous injection on day 4 of 12.5 L of a rabbit antimurine platelet antiserum (Accurate Chemical and Scientific Corporation) via the tail vein, diluted with saline to 100 L just before the injection. Surgery and ligation were then performed on day 5. On days 5, 12, and 19, the circulating platelet numbers equaled 3.9Ϯ0.48ϫ10 4 (nϭ7), 2.3Ϯ0.24ϫ10 5 (nϭ6), and 3.9Ϯ0.18ϫ10 5 (nϭ6) platelets/L, respectively.
Fibrinogen Depletion by Ancrod in C57BL/6J Mice
Fibrinogen depletion was induced with the specific fibrinogendegrading enzyme ancrod, 16 derived from snake venom. The plasma fibrinogen concentration was measured via a fibrin polymerization clotting assay. 17 In an acute or early depletion experiment, a bolus of ancrod at 40 U/kg was injected twice via the tail vein, 8 hours before and 2 days after the surgical ligation procedure. In the chronic or late depletion experiment, the same dose of ancrod was injected, starting 6 days after the ligation procedure and repeated on days 8, 10, and 12. In both experiments, animals were killed 14 days after the ligation procedure. Control groups in each experimental protocol received vehicle (saline) injection using the same schedule as the ancrod injections.
An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org. 
Results
Microscopic Changes in Ligated Carotid Arteries
Shortly after ligation, carotid artery cross sections were stained with an antiplatelet antiserum. Figures 1a and 1b show that the antiserum does not react with red blood cells in buffy coat or murine spleen cells but strongly stains a platelet-rich thrombus forming after vessel-wall injury (Figure 1c ). As early as 1 day after ligation, platelet microaggregates and leukocytes decorated with platelets could be observed adjacent to the endothelium (Figure 1d ). At 3 days, platelets and platelet-decorated leukocytes (rosettes) were found lining the endothelium (Figure 1e ) in addition to clear vascular infiltration by leukocytes ( Figure 2b ). Platelet-rich thrombi were present both on the ligated vessel wall and in the lumen after 1 week (Figure 1f Myeloperoxidase and CD45 staining of cross sections taken on days 3, 7, and 14 identified strongly stained cells primarily in the adventitia, but positive cells were also found in the lumen as well as lining the endothelium on day 3 and week 1 (not shown). Tissue factor was found not only in cross sections of wt-mice carotid arteries in between the elastic laminae but also within the early fibrin layers on day 3, where it surrounded the adhering leukocytes. It was also found associated with luminal monocytoid cells ( Figure 4a ). The neointima stained for tissue factor after 2 weeks (Figure 4d ), whereas areas adjacent to the intima and luminal cells (Figures 4b and 4c ) were found to be strongly positive 1 and 2 weeks after ligation. Tissue factor was strongly associated with intraluminal monocytes but only weakly with intraluminal granulocytes.
Quantitation of Neointima Formation
Image analysis of cross sections of the ligated carotid artery of control mice revealed no major remodeling of the outer vessel wall over a period of 3 weeks. No significant change occurred of the area within the external elastic lamina (EEL) in the immediate neighborhood of the ligation, ie, in the cross-sectional area where the degree of smooth muscle cell proliferation was maximal ( Figure 5 ). In contrast, a significant reduction of the area within the internal elastic lamina (IEL) was already observed 1 week after the ligation. Calculation of the media index confirmed that after 1 week, medial thickening had occurred, in agreement with a rapid onset of smooth muscle cell activation. More importantly, a rapid reduction of the luminal area was found, corresponding to a progressive and intense luminal stenosis up to 75% ( Figure  5 ). These data suggested observation times of 1 and 2 weeks to be optimal for the study of smooth muscle cell proliferation in response to the modulation of hemostasis in the various gene-deficient mice. After 1 week of ligation, thrombotic occlusions were present along with a developing neointima ( Figure 2c ), which occupied most of the lumen after 2 weeks ( Figure 2d ).
Gene Deficiencies and Luminal Stenosis
Comparison of the degree of luminal stenosis as a function of the genetic background identified small differences in the degree of stenosis 1 and 2 weeks after ligation ( Figure 6 ). Because the variable degree of C57BL/6J background limited direct comparisons between different strains, the degree of stenosis measured in gene-deficient mice was always matched to that in wt controls with identical genetic background. Thus, hemophilia A mice showed strongly reduced stenosis at 1 week, when stenosis was expressed as a percentage of the cross-sectional area within the internal elastic membrane occupied by neointima (11Ϯ3.6% versus 26Ϯ2.8% for matched controls, PϽ0.01) and at 2 weeks (21Ϯ4.7% versus 60Ϯ3.5% for matched controls, PϽ0.01 by Student's unpaired t test) despite substantial medial smooth muscle cell activation (mean media index in FVIII Ϫ/Ϫ mice was 0.31Ϯ0.02 after 1week and 0.34Ϯ0.02 after 2 weeks). Thus, overall, neointima formation was 3-fold lower as a consequence of the FVIII gene deficiency. In contrast, neointima formation in u-PA Ϫ/Ϫ mice was enhanced at 1 week (38Ϯ7.0% versus 19Ϯ2.7% for matched controls, PϽ0.05) and at 2 weeks (77Ϯ5.6% versus 43Ϯ8.0% for matched 
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Artery Ligation and Neointima Development controls, PϽ0.01); ie, neointima formation was increased almost 2-fold (media index in u-PA Ϫ/Ϫ mice was 0.4Ϯ0.04 after 1 week and 0.28Ϯ0.026 after 2 weeks). No differences were observed between t-PA Ϫ/Ϫ mice and matched controls, although a trend to higher luminal stenosis was found after 2 weeks. Likewise, no differences were observed in mice deficient in PAI-1. Mice deficient in the plasmin inhibitor ␣ 2 -AP revealed reduced neointima formation at 1 week (14Ϯ2.6% versus 26Ϯ2.8% for matched controls, PϽ0.01) but showed identical neointimas after 2 weeks ( Figure 6 ). In all of these cases, the media index was increased and comparable with that of the matched controls (not shown). Leukocyte adhesion to the luminal vessel wall in ligated u-PA Ϫ/Ϫ and FVIII Ϫ/Ϫ (Figure 2f ) mice on day 3 was comparable with that in control mice, indicating that the early cellular inflammation did not depend on the amount of fibrin formed per se.
Neointimal Proliferation and Platelet Activation
Because deficient luminal fibrinolysis in u-PA Ϫ/Ϫ mice was associated with enhanced smooth muscle cell migration and deficient coagulation in FVIII Ϫ/Ϫ mice with a drop in smooth muscle cell migration, the relation between coagulation and neointima formation was additionally investigated via platelet depletion. Figure 7 shows that as a consequence of partial thrombocytopenia, neointima formation dropped from 30Ϯ1.5% in untreated to 12Ϯ2.3% in busulfan-treated animals after 1 week and from 45Ϯ3.9% to 25Ϯ4.8% after 2 weeks (PϽ0.01, nϭ6 to 8). The media index was increased in all cases and was comparable with that of the control (not shown), confirming that the busulfan treatment had no impact on smooth muscle cell activation, in agreement with earlier findings. 15 Analysis of cellular infiltration in thrombocytopenic mice on day 3 revealed almost complete absence of leukocytes adhering or infiltrating the endothelial layer (Figure 2e) , in agreement with a critical role of platelets in inflammation.
Neointimal Proliferation and Fibrin Formation
To finally confirm a role for fibrin in smooth muscle cell migration, fibrinogen-depletion studies were undertaken. Both an early depletion of fibrinogen (injections of ancrod just before ligation and on day 2) as well as a later and more chronic fibrinogen depletion (injection of ancrod on days 6, 8, 10, and 12) reduced neointima formation, analyzed 2 weeks after ligation (Figure 8 ). After early fibrinogen depletion, luminal stenosis equaled 29Ϯ4.4%, compared with 53Ϯ8.4% for vehicle-injected animals (PϽ0.01). Thus, early fibrinogen depletion reduced neointima formation by Ϸ50%. Although some fluctuation was observed between the early and late control groups, stenosis in these control groups was not significantly different (Pϭ0.163), and both groups did not differ from the ligated noninjected C57BL/6J mice, analyzed at week 2 (42Ϯ5.1%). Delayed ancrod-induced fibrinogen depletion also was associated with a significant drop in neointima formation, from 38Ϯ5.3% in the vehicle-injected controls to 17Ϯ3.4% (PϽ0.01) or 45% of the control value. Fibrinogen depletion had no effect on medial proliferation (not shown). Likewise, the early fibrinogen depletion did not interfere with leukocyte adhesion and infiltration on day 3 (not shown). 
Discussion
Our present findings are in line with older observations 3 ; ie, blood stasis does not provoke immediate blood coagulation but rather induces delayed thrombosis over 1 to 7 days, coinciding with inflammatory responses in the blood vessel. Therefore, in the present study, we have investigated how platelets and leukocytes participate in the inflammatory response and how cellular inflammation is linked to thrombosis and smooth muscle cell proliferation. Hypoxia causes initial endothelial cell activation, with a rise in endothelial intracellular Ca 2ϩ concentrations 18 and cellular production of, for example, platelet-activating factor. 19 Thus, hypoxia can trigger inflammation, because changes in adhesive and inflammatory characteristics of activated endothelial cells result in the recruitment of leukocytes, a process mediated via adhesion molecules such as E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 20 and also P-selectin. 21 That Pselectin-mediated cellular interactions are important in the genesis of ligation-induced inflammation is beautifully illustrated by the findings of Kumar et al, 9 which show that in P-selectin gene-deficient mice, inflammatory cells do not accumulate in the vessel wall at 3 days after ligation.
Our present findings show that during stasis, activated platelets adhere to leukocytes and that platelet-leukocyte rosettes interact with endothelial cells, interactions which are mediated via platelet P-selectin both for platelet-granulocyte rosettes 22 and platelet-monocyte rosettes. 23 The critical role of platelets in mediating vessel-wall inflammation by leukocytes was clear from the almost complete absence of adhering leukocytes 3 days after ligation in thrombocytopenic wt mice, indicating that the crucial role of P-selectin in inflammation 9 largely pertains to platelet P-selectin-assisted leukocyte deposition on activated endothelium.
Although endothelial cells can be induced to express tissue factor, these observations largely pertain to cell cultures. 24 Recent convincing evidence indicates that leukocytes are a source of active blood-borne tissue factor. 25 Østerud et al 24 have shown that addition of platelets to activated monocytes markedly enhances the tissue factor activity of the monocytes. They suggest that in platelet-monocyte rosettes, the monocyte provides the tissue factor apoprotein and the platelets provide the phosphatidyl serine environment re- quired for tissue-factor activity. This interpretation then explains why inflammation via deposition of plateletmonocyte rosettes delivers tissue factor and causes fibrin formation at day 3 in a fine layer overlying the endothelium, enveloping adherent leukocytes. Luminal monocytes also were positive for tissue factor, explaining why fibrin was found surrounding these cells but not granulocytes. Tissue factor in those cells was upregulated over the 2-week observation period, a finding in agreement with the knowledge that hypoxia upregulates tissue-factor expression in monocytes, 26 additionally substantiating that stasis-induced hypoxia is involved in cellular activation processes.
Recently, fibrin has been demonstrated to directly support smooth muscle cell migration in vitro. 27 Because the present ligation model, in addition to producing vessel-wall inflammation-dependent coagulation, also triggers fast and reproducible smooth muscle cell migration and proliferation, we have additionally studied the link in this model between coagulation and smooth muscle cell activity. In contrast to previous investigations, 8, 9 we did not analyze the ligated vessel longitudinally but analyzed the entire vessel crosssectionally, focusing on the area with the highest degree of neointima formation, close to the ligation. This may explain the lack of inward remodeling of the EEL in our model compared with these studies. We studied neointimal proliferation in various mice strains with well-characterized gene deficiencies of the coagulation factor VIII, the fibrinolytic enzymes t-PA and u-PA, and the fibrinolytic enzyme inhibitors PAI-1 and ␣ 2 -AP, taking care to correct for differences in murine genetic backgrounds.
In u-PA Ϫ/Ϫ mice, ligation induced enhanced fibrin formation, findings in agreement with the occurrence and persistence of mural thrombosis, also in electrically injured arteries of u-PA gene-deficient mice. 28 In the injury model, u-PA significantly enhanced arterial neointima formation, 28 but in the present study without medial damage, a larger neointima was found in u-PA Ϫ/Ϫ mice than in wt controls 2 weeks after ligation, at which time point thrombi were completely invaded by smooth muscle cells. Thus, in the present ligation model, u-PA is not required to mediate smooth muscle cell migration, and the larger neointima in u-PA Ϫ/Ϫ mice rather coincides with enhanced luminal fibrin formation, observed histochemically in the carotid arteries of these mice.
The opposite finding, that reduced fibrin formation in the ligated carotid artery of hemophilia A mice coincides with strongly reduced neointima formation, leads us to conclude that fibrin is required for smooth muscle cell migration into the vessel wall lumen. Histologically, smooth muscle cells were indeed seen migrating over fibrin matrix in u-PA Ϫ/Ϫ mice. These data support a model in which fibrinolytic modifications only affect neointima formation by modulating the luminal fibrin content. Thus, the absence of plasma ␣ 2 -AP strongly reduced neointima formation, probably as a consequence of enhanced luminal fibrinolysis. However, this effect was no longer detectable 2 weeks after ligation. The absence of t-PA had no impact on smooth muscle cell activation and proliferation, suggesting that luminal t-PA is efficiently inhibited in wt mice, in contrast to luminal u-PA. The absence of PAI-1 had no impact on the degree of smooth muscle cell activation and proliferation. This finding agrees with our recent observation that murine PAI-1 is essentially confined to the vessel wall and present in plasma and platelets only at extremely low levels. 29 Platelet-depletion experiments confirmed that in addition to a reduction in inflammation, there is less neointima formation. Sirois et al, 15 studying rats pretreated with busulfan, have already shown that inhibition of neointima formation is mediated by the absence of platelets rather than by drug-related inhibition of smooth muscle cell proliferation. A possible decrease in leukocyte count after busulfan, although statistically not significant, may also have contributed to a reduction in neointima development.
Despite their very different outcome in terms of neointima formation, u-PA Ϫ/Ϫ and FVIII Ϫ/Ϫ mice and fibrinogendepleted mice showed comparable vessel wall inflammation at day 3, confirming that the platelet-leukocyte-dependent inflammation precedes coagulation reactions and neointima development.
Tissue factor is expressed in the newly forming intima, suggestive of continued activation of coagulation throughout the observation period. The experiments with early or delayed fibrinogen depletion resulting in a partial reduction in neointima formation suggest that the persistent presence of fibrin remains crucial. These data confirm that smooth muscle cells use fibrin matrices to migrate. Together with the larger neointima in u-PA Ϫ/Ϫ mice, these fibrinogen-depletion experiments performed in wt mice additionally show that a deficient generation of thrombin per se is not responsible for the weak neointima development in FVIII Ϫ/Ϫ mice and that a diminished endothelial cell activation by thrombin 30 would not be the basis for reduced neointima formation.
In conclusion, this in vivo study shows that blood stasis and hypoxia cause activation of platelets, endothelial cells, and monocytes. It additionally shows that stasis-induced inflammation largely results from the adhesion to endothelium of rosettes between activated platelets and leukocytes. The concentration on the endothelium of monocytic tissue factor and platelet phospholipids triggers blood coagulation, resulting in the formation of endothelial fibrin layers together with the inflammation. The fibrin matrix, formed over an interval of several days, is then actively used as a support by migrating smooth muscle cells during formation of a neointima. Interruption of inflammation and tissue factor deposition via platelet depletion and reduction of the coagulation efficiency via fibrinogen depletion or a FVIII deficiency all result in reduced fibrin deposition and ultimately in diminished neointima formation. 
